Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Haemonetics (HAE) Shares Repurchased (2018 - 2025)

Haemonetics (HAE) has 9 years of Shares Repurchased data on record, last reported at $150.0 million in Q1 2025.

  • For Q1 2025, Shares Repurchased changed N/A year-over-year to $150.0 million; the TTM value through Dec 2025 reached $150.0 million, changed N/A, while the annual FY2025 figure was $225.0 million, N/A changed from the prior year.
  • Shares Repurchased reached $150.0 million in Q1 2025 per HAE's latest filing, up from $50.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $150.0 million in Q1 2025 and bottomed at $150.0 million in Q1 2025.